Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser-assisted versus traditional stromal vascular fraction harvesting for knee osteoarthritis
RBR-2khq5gcPhase 2Recruiting
- Sponsor
- Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
- Start
- Mar 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose stromal vascular fraction in knee osteoarthritis (OA) (2 arms), sponsored by Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad. Primary endpoint: Cellular composition of stromal vascular fraction. Started Mar 2025; status: recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-2khq5gc.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2khq5gc.